Area of research
Oncology · Molecular Biology
Research interest
Research interests include Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, and Psoriasis: Treatment and Pathogenesis.
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma
The Risk of Melanoma in Airline Pilots and Cabin Crew
DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
Metformin and trametinib have synergistic effects on cell viability and tumor growth in<i>NRAS</i>mutant cancer
<i>Mycoplasma pneumoniae</i>‐associated mucositis – case report and systematic review of literature